These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6115058)

  • 1. Beta-adrenoceptor stimulant properties of amidoalkylamino-substituted 1-aryl-2-ethanols and 1-(aryloxy)-2-propanols.
    Barlow JJ; Main BG; Snow HM
    J Med Chem; 1981 Mar; 24(3):315-22. PubMed ID: 6115058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1-Alkylamino-3-(2-thiazolyloxy)-2-propanols. A novel class of mixed myocardial beta-stimulants-beta-blockers.
    Edwards JA; Berkoz B; Lewis GS; Halpern O; Fried JH; Strosberg AM; Miller LM; Urich S; Liu F; Roszkowski AP
    J Med Chem; 1974 Feb; 17(2):200-3. PubMed ID: 4148933
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardioselective beta-adrenergic blocking agents. 1. 1-((3,4-Dimethoxyphenethyl)amino)-3-aryloxy-2-propanols.
    Hoefle ML; Hastings SG; Meyer RF; Corey RM; Holmes A; Stratton CD
    J Med Chem; 1975 Feb; 18(2):148-52. PubMed ID: 235644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta-Adrenergic blocking agents. 17. 1-Phenoxy-3-phenoxyalkylamino-2-propanols and 1-alkoxyalkylamino-3-phenoxy-2-propanols.
    Smith LH; Tucker H
    J Med Chem; 1977 Dec; 20(12):1653-6. PubMed ID: 22750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-adrenergic blocking agents. 20. (3-Hydroxyprop-1-enyl)-substituted 1-(aryloxy)-3-(alkylamino)propan-2-ols.
    Tucker H
    J Med Chem; 1980 Oct; 23(10):1122-6. PubMed ID: 6106716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The positive chronotropic effect induced by BRL 37344 and CGP 12177, two beta-3 adrenergic agonists, does not involve cardiac beta adrenoceptors but baroreflex mechanisms.
    Tavernier G; Galitzky J; Bousquet-Melou A; Montastruc JL; Berlan M
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1083-90. PubMed ID: 1361569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-adrenergic blocking agents. 22. 1-Phenoxy-3-[[(substituted-amido) alkyl]amino]-2-propanols.
    Lare MS; Smith LH
    J Med Chem; 1982 Nov; 25(11):1286-92. PubMed ID: 6128420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-adrenergic blocking agents. 19. 1-Phenyl-2-[[(substituted-amido)alkyl]amino]ethanols.
    Large MS; Smith LH
    J Med Chem; 1980 Feb; 23(2):112-7. PubMed ID: 6102152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioselectivity of beta-adrenoceptor blocking agents 1. 1-[(4-Hydroxyphenethyl)amino]-3-(aryloxy)propan-2-ols.
    Rzeszotarski WJ; Gibson RE; Eckelman WC; Reba RC
    J Med Chem; 1979 Jun; 22(6):735-7. PubMed ID: 37339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. beta 1-selective adrenoceptor antagonists. 2. 4-ether-linked phenoxypropanolamines.
    Machin PJ; Hurst DN; Bradshaw RM; Blaber LC; Burden DT; Fryer AD; Melarange RA; Shivdasani C
    J Med Chem; 1983 Nov; 26(11):1570-6. PubMed ID: 6138435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dog.
    Berlan M; Galitzky J; Bousquet-Melou A; Lafontan M; Montastruc JL
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1444-51. PubMed ID: 7908057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenergic agents. 4. Substituted phenoxypropanolamine derivatives as potential beta-adrenergic agonists.
    Kaiser C; Jen T; Garvey E; Bowen WD; Colella DF; Wardel JR
    J Med Chem; 1977 May; 20(5):687-92. PubMed ID: 16136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cardiovascular effects of ICI 118,587: A beta 1-adrenoceptor partial agonist.
    Nuttall A; Snow HM
    Br J Pharmacol; 1982 Oct; 77(2):381-8. PubMed ID: 6128041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenergic receptor agonists. Benzofuranylethanolamines.
    Lövgren K; Hedberg A; Nilsson JL
    J Med Chem; 1980 Jun; 23(6):624-7. PubMed ID: 6104731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. beta 1-selective adrenoceptor antagonists. 1. Synthesis and beta-adrenergic blocking activity of a series of binary (aryloxy)propanolamines.
    Kierstead RW; Faraone A; Mennona F; Mullin J; Guthrie RW; Crowley H; Simko B; Blaber LC
    J Med Chem; 1983 Nov; 26(11):1561-9. PubMed ID: 6138434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent, selective benzenesulfonamide agonists of the human beta 3 adrenergic receptor.
    Weber AE; Mathvink RJ; Perkins L; Hutchins JE; Candelore MR; Tota L; Strader CD; Wyvratt MJ; Fisher MH
    Bioorg Med Chem Lett; 1998 May; 8(9):1101-6. PubMed ID: 9871716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioselectivity as a function of molecular structure in beta-adrenoceptor blocking agents of the 1-(para-substituted aryloxy)-3-(isopropylamino)propan-2-ol type.
    Erez M; Shtacher G; Weinstock M
    J Med Chem; 1978 Sep; 21(9):982-4. PubMed ID: 31488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta 1-selective adrenoceptor antagonists. 3. 4-Azolyl-linked phenoxypropanolamines.
    Machin PJ; Hurst DN; Bradshaw RM; Blaber LC; Burden DT; Melarange RA
    J Med Chem; 1984 Apr; 27(4):503-9. PubMed ID: 6142955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of beta-adrenoceptor subtypes in the ferret urinary bladder in vitro and in vivo.
    Takeda H; Igawa Y; Komatsu Y; Yamazaki Y; Akahane M; Nishizawa O; Ajisawa Y
    Eur J Pharmacol; 2000 Sep; 403(1-2):147-55. PubMed ID: 10969156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist-induced desensitization of beta-adrenoceptor function in humans. Subtype-selective reduction in beta 1- or beta 2-adrenoceptor-mediated physiological effects by xamoterol or procaterol.
    Brodde OE; Daul A; Michel-Reher M; Boomsma F; Man in 't Veld AJ; Schlieper P; Michel MC
    Circulation; 1990 Mar; 81(3):914-21. PubMed ID: 1968366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.